PCSK9 inhibitors in the prevention of vascular events - a review of current evidence
Background. Atherosclerotic cardiovascular disease remains the leading cause of mortality worldwide. Despite the widespread use of high-intensity statins, many patients fail to achieve target low-density lipoprotein cholesterol (LDL-C) levels and remain at high residual risk. Proprotein convertase...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Kazimierz Wielki University
2026-04-01
|
| Cyfres: | Journal of Education, Health and Sport |
| Pynciau: | |
| Mynediad Ar-lein: | https://apcz.umk.pl/JEHS/article/view/70057 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|